Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2002
07/03/2002EP1218348A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
07/03/2002EP1218005A2 Vitronectin receptor antagonists
07/03/2002EP0966466B1 PYRROLO 3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
07/03/2002CN1356995A Substituted benzimidazole
07/03/2002CN1356903A Synthesis and crystallization of piperazine ring-contg. compounds
07/03/2002CN1356328A Terta-(1,4,8,9-tetraaza) benzophenanthrene metal-phthalocyanine compound and its synthesizing process
07/02/2002US6414157 Compounds having high affinity for 5-ht1b and 5-ht1c serotonin receptor; antidepressants
07/02/2002US6414153 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease
07/02/2002US6414149 Treating diabetes, treating or preventing diabetic complications
07/02/2002US6414008 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
07/02/2002US6414003 Antiulcer agents
07/02/2002US6413991 Antidiabetic agents; dietetics
07/02/2002US6413981 Drug-resistant gram positive and gram negative bacteria; pneumonia; infections of upper and lower respiratory tract, skin, soft tissue, bones and joints
07/02/2002US6413980 Nitrogen containing heterobicycles as factor Xa inhibitors
07/02/2002US6413978 Basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use
07/02/2002US6413971 Antiproliferative, -carcinogenic, -tumor and -diabetic agents; binding to or modulating the human kinase insert-domain-containing receptor (kdr) or the murine fetal liver kinase 1 (flk-1) receptor; vasculogenesis; angiogenesis
07/02/2002US6413959 Neurokinin(tachykinin) antagonists
07/02/2002US6413958 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-barr virus; enzyme inhibitors
07/02/2002US6413956 Substituted 4-oxo-quinoline-3-carboxamides
07/02/2002US6413955 1,8-naphthyridines or 5-thio-1,8-naphthyridines or 5-oxo-1,8-naphthyridines; bone resorption, osteoporosis, vascular rest-enosis, diabetic retinopathy, macular degeneration, angio-genesis, atherosclerosis, inflammatory arthritis, cancer
07/02/2002CA2194984C 4-indole derivatives as serotonin agonists and antagonists
07/02/2002CA2047283C Pyrazolopyridine compound and processes for preparation thereof
06/2002
06/27/2002WO2002050074A1 Process for preparing a substantially pure gamma phase quinacridone pigment of large particle size
06/27/2002WO2002050073A1 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
06/27/2002WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050062A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
06/27/2002WO2002050061A1 Piperazine derivatives for treatment of bacterial infections
06/27/2002WO2002049993A2 High affinity small molecule c5a receptor modulators
06/27/2002WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines
06/27/2002WO2002022602A3 Triazole compounds useful as protein kinase inhibitors
06/27/2002WO2002014318A8 Liquid crystalline 3,4:9,10-perylenetetracarboxylic acid diimides
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002WO2001080857A9 Zolpidem hemitartrate
06/27/2002US20020082425 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives
06/27/2002US20020082424 Alkylating an aryl halide with 1,3-dichloropropene and n-tetrabutylammonium iodide catalyst for forming vinyl chloride compound which is subjected to cyclization using tribuytyl tin hydride, catalyst and toluene as the solvent
06/27/2002US20020082420 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
06/27/2002US20020081626 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample
06/27/2002CA2433020A1 Process for preparing a substantially pure gamma phase quinacridone pigment of large particle size
06/27/2002CA2431592A1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
06/26/2002EP1217000A1 Inhibitors of factor Xa and factor VIIa
06/26/2002EP1216257A1 Compounds for the treatment of ischemia
06/26/2002EP1216244A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d 4? antagonists
06/26/2002EP1216234A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
06/26/2002EP1216231A2 INHIBITORS OF FACTOR Xa
06/26/2002EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
06/26/2002EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
06/26/2002CN1355803A Cucurbiturils and method for synthesis
06/26/2002CN1355793A Novel synthesis of piperazine ring
06/26/2002CN1355701A Urea substituted imidazoquinolines
06/26/2002CN1086704C Compound having antihypertensive, cardioprotective, anti-ischemic and ant ilipolytic functions
06/26/2002CN1086698C Oxadizoles, processes for their preparation and their use as medicaments
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410731 Enhanced lipophilicity, bioavailability; made via a cascade radical 4+1 annulation including reacting a precursor with an arylisonitrile
06/25/2002US6410580 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
06/25/2002US6410555 Antiepileptic agents; headaches
06/25/2002US6410550 Aryl fused azapolycyclic compounds
06/25/2002US6410547 Phenylpyridine derivatives useful as phosphodiesterase inhibitors
06/25/2002US6410540 Inhibitors of p38-αkinase
06/25/2002US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents
06/25/2002CA2048110C Imidazopyridine derivatives and their use
06/20/2002WO2002048301A1 Ligand and complex for catalytically bleaching a substrate
06/20/2002WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
06/20/2002WO2002048148A2 Pyrazolopyridine derivatives
06/20/2002WO2002048147A2 Pyrazolopyridines
06/20/2002WO2002048146A2 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
06/20/2002WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
06/20/2002WO2002048144A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
06/20/2002WO2002048138A1 Antimicrobial quinolones
06/20/2002WO2002048117A1 Quinazolinone derivatives
06/20/2002WO2002048116A2 Inhibitors of hepatitis c virus ns3 protease
06/20/2002WO2002048115A2 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
06/20/2002WO2002048113A1 Cyclization process step in the making of quinolones and naphthyridines
06/20/2002WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
06/20/2002WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
06/20/2002WO2002047679A2 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2002020013A3 A method for treating allergies using substituted pyrazoles
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2002008226A3 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
06/20/2002WO2002004455A3 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
06/20/2002WO2002004422A3 Heterocycle carboxamides as antiviral agents
06/20/2002US20020077487 As labeling reagents for a variety of biological applications
06/20/2002US20020077480 Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
06/20/2002US20020077474 Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands
06/20/2002US20020077473 Triazatrinaphthyrins and the use thereof
06/20/2002US20020077338 HIV protease inhibitors
06/20/2002US20020077337 Chemical compounds
06/20/2002US20020077332 Zolpidem hemitartrate
06/20/2002US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis
06/20/2002US20020077327 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/20/2002US20020077325 New camptothecin analogue compounds
06/20/2002US20020077321 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
06/20/2002US20020073896 Process for preparing a substantially pure gamma phase quinacridone pigment of large particle size
06/20/2002CA2432825A1 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002CA2431406A1 Quinazolinone derivatives
06/20/2002CA2431326A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
06/20/2002CA2429951A1 Antimicrobial quinolones
06/19/2002EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them
06/19/2002EP1215205A1 Tuned multifunctional linker molecules for electronic charge transport through organic-inorganic composite structures and use thereof